[1] Shieh WJ. Human adenovirus infections in pediatric population - an update on clinico-pathologic correlation. Biomed J, 2022; 45, 38−49. doi:  10.1016/j.bj.2021.08.009
[2] Wang FM, De R, Han ZZ, et al. High-frequency recombination of human adenovirus in children with acute respiratory tract infections in Beijing, China. Viruses, 2024; 16, 828. doi:  10.3390/v16060828
[3] Park A, Lee C, Lee JY. Genomic evolution and recombination dynamics of human adenovirus D species: insights from comprehensive bioinformatic analysis. J Microbiol, 2024; 62, 393−407. doi:  10.1007/s12275-024-00112-5
[4] Gonzalez G, Hayes M, Balansay M, et al. Two novel recombinant human mastadenovirus D genotypes associated with acute respiratory illness. J Med Virol, 2023; 95, e28653. doi:  10.1002/jmv.28653
[5] Wang JJ, Jing L, Duan YL, et al. Identification of novel recombinant human adenovirus genotype B117 from pediatric cases, China. Emerg Infect Dis, 2026; 32, 950−8.
[6] Windheim M, Hilgendorf A, Burgert HG. Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways. Curr Top Microbiol Immunol, 2004; 273, 29−85.
[7] Oliveira ERA, Bouvier M. Immune evasion by adenoviruses: a window into host-virus adaptation. FEBS Lett, 2019; 593, 3496−503. doi:  10.1002/1873-3468.13682
[8] Persson BD, John L, Rafie K, et al. Human species D adenovirus Hexon capsid protein mediates cell entry through a direct interaction with CD46. Proc Natl Acad Sci USA, 2020; 118, e2020732118.
[9] Mundy RM, Baker AT, Bates EA, et al. Broad sialic acid usage amongst species D human adenovirus. npj Viruses, 2023; 1, 1. doi:  10.21203/rs.3.rs-3033136/v1
[10] MacNeil KM, Dodge MJ, Evans AM, et al. Adenoviruses in medicine: innocuous pathogen, predator, or partner. Trends Mol Med, 2023; 29, 4−19.